Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

Conditions:   Acute Myeloid Leukemia;   Chronic Myelomonocytic Leukemia;   Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells;   Myelodysplastic Syndrome;   Myeloproliferative Neoplasm;   Recurrent Acute Myeloid Leukemia;   Refractory Acute Myeloid Leukemia;   Secondary Acute M yeloid Leukemia Interventions:   Drug: Azacitidine;   Drug: Decitabine;   Drug: Salsalate;   Drug: Venetoclax Sponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials